Clinical Trial Update: Clinical Trial of the Efficacy and Safety of Raphamin in Combined Treatment of Community-acquired Pneumonia [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the efficacy and safety of Raphamin in combination therapy for community-acquired pneumonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia
• Pneumonia

Drugs mentioned

• Raphamin (Raphamin)

Snippet

Sponsor: Materia Medica Holding | Conditions: Community-acquired Pneumonia, Pneumonia | Phase 3 | Status: COMPLETED